Generic-drug maker Teva steals market share from Big Pharma - Aug. 5, 2009
Jewish Values Investors JLens Target Israeli Company
/cloudfront-us-east-2.images.arcpublishing.com/reuters/G5JWOXLOQZIDLHFUUAR3HXPXEQ.jpg "Teva settles shareholder lawsuit over generic drug pricing for $420 mln | Reuters")
Teva settles shareholder lawsuit over generic drug pricing for $420 mln | Reuters
Teva Pharmaceutical's Remarkable Growth In 2023: A Success Story | Seeking Alpha
Teva Pharmaceutical Industries Limited (TEVA): history, ownership, mission, how it works & makes money
Pharma giant Teva looks to steady ship with new CEO in coming weeks | The Times of Israel
Teva Has Turned the Corner
Allergan becomes largest shareholder in Teva - Globes
Teva Pharmaceutical basic share number 2011-2022 | Statista
US88163VAD10 - Teva Pharmaceutical Finance Co LLC Stock - Stock Price, Institutional Ownership, Shareholders
Is TEVA A Good Stock To Buy?
Teva Pharmaceutical Industries Limited (NYSE:TEVA) down to US$10b market cap, but institutional owners may not be as affected after a year of 7.9% returns - Simply Wall St News
Teva settles shareholder lawsuit over generic drug | Business Insurance
Teva Pharmaceuticals has acquired success with Actavis Generics | World Finance
Teva Pharmaceuticals soars after Warren Buffett's Berkshire Hathaway discloses a stake (TEVA) | Markets Insider
Teva Has Turned the Corner
Teva Pharmaceutical's Remarkable Growth In 2023: A Success Story | Seeking Alpha
Teva Plunges as U.S. Sales Drop Amid Generic Price Erosion - Bloomberg
DEF 14A
Teva Pharmaceutical's Stock Tumbles on Outlook - WSJ
Teva Pharmaceutical Industries Limited: Shareholders Board Members Managers and Company Profile | US8816242098 | MarketScreener
World's biggest generic-drug empire created - ISRAEL21c
Infographic: Teva Pharmaceuticals (TEVA) Q1 2020 earnings results | AlphaStreet
$300 million Teva bet: Will Norway's wealth fund and ION regret investing in the phar | Ctech
